SES Performance Review Board, 51820 [E8-20571]

Download as PDF 51820 Federal Register / Vol. 73, No. 173 / Friday, September 5, 2008 / Notices promote sustainable growth in output. To further its long–run objectives, the Committee in the immediate future seeks conditions in reserve markets consistent with maintaining the federal funds rate at an average of around 2 percent. By order of the Federal Open Market Committee, August 26, 2008. Brian F. Madigan, Secretary, Federal Open Market Committee. [FR Doc. E8–20558 Field 9–4–08; 8:45 am] BILLING CODE 6210–01–S FEDERAL TRADE COMMISSION SES Performance Review Board AGENCY: ACTION: Federal Trade Commission Notice SUMMARY: Notice is hereby given of the appointment of members to the Federal Trade Commission’s Performance Review Board. FOR FURTHER INFORMATION CONTACT: Karen Leydon, Director of Human Resources, 600 Pennsylvania Avenue NW, Washington, DC 20580, (202) 3262633. SUPPLEMENTARY INFORMATION: Publication of the Performance Review Board (PRB) membership is required by 5 U.S.C. 4314 (c)(4). The PRB reviews and evaluates the initial appraisal of a senior executive’s performance by the supervisor, and makes recommendations regarding performance ratings, performance awards, and pay-for-performance pay adjustments to the FTC Chairman. The following individuals have been designated to serve on the FTC’s Performance Review Board: Charles H. Schneider, Chairman William Blumenthal Pauline M. Ippolito Lydia B. Parnes David P. Wales By direction of the Commission. mstockstill on PROD1PC66 with NOTICES Donald S. Clark Secretary [FR Doc. E8–20571 Filed 9–4–08: 8:45 am] BILLING CODE 6750–01–S VerDate Aug<31>2005 18:40 Sep 04, 2008 Jkt 214001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10151 and CMS– 10152] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Data Collection for Medicare Beneficiaries Receiving Implantable Cardioverter-defibrillator for Primary Prevention of Sudden Cardiac Death; Use: The Centers for Medicare and Medicaid Services (CMS) provides coverage for implantable cardioverter-defibrillators (ICDs) for secondary prevention of sudden cardiac death based on extensive evidence showing that use of ICDs among patients with a certain set of physiologic conditions are effective. Accordingly, CMS considers coverage for ICDs reasonable and necessary under Section 1862 (a)(1)(A) of the Social Security Act. However, evidence for use of ICDs for primary prevention of sudden cardiac death is less compelling for certain patients. To encourage responsible and appropriate use of ICDs, CMS issued a Decision Memo for Implantable Defibrillators on January 27, 2005, indicating that ICDs will be covered for primary prevention of sudden cardiac death if the beneficiary is enrolled in either an FDA-approved category B IDE clinical trial (42 CFR 405.201), a trial AGENCY: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 under the CMS Clinical Trial Policy (NCD Manual § 310.1) or a qualifying prospective data collection system (either a practical clinical trial or prospective systematic data collection, which is sometimes referred to as a registry). Form Number: CMS–10151 (OMB# 0938–0967); Frequency: Reporting—Quarterly; Affected Public: Business or other for-profit and not-forprofit institutions; Number of Respondents: 1,217; Total Annual Responses: 50,000; Total Annual Hours: 12,500. 2. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Data collection for Medicare Beneficiaries Receiving FDG Positron Emission Tomography (PET) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and All Other Cancers Use: In the Decision Memo #CAG–00181N issued on January 27, 2005, CMS determined that the evidence is sufficient to conclude that for Medicare beneficiaries receiving FDG positron emission tomography (PET) for brain, cervical, ovarian, pancreatic, small cell lung, and testicular cancers is reasonable and necessary only when the provider is participating in and patients are enrolled in a systematic data collection project. CMS will consider prospective data collection systems to be qualified if they provide assurance that specific hypotheses are addressed and they collect appropriate data elements. The data collection should include baseline patient characteristics; indications for the PET scan; PET scan type and characteristics; FDG PET results; results of all other imaging studies; facility and provider characteristics; cancer type, grade, and stage; long-term patient outcomes; disease management changes; and anti-cancer treatment received. Form Number: CMS–10152 (OMB# 0938–0968); Frequency: Reporting—On occasion; Affected Public: Business or other for-profit and not-for-profit institutions; Number of Respondents: 2,000; Total Annual Responses: 50,000; Total Annual Hours: 4,167. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS’ Web Site at https://www.cms.hhs.gov/ PaperworkReductionActof1995, or Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786– 1326. In commenting on the proposed information collections please reference E:\FR\FM\05SEN1.SGM 05SEN1

Agencies

[Federal Register Volume 73, Number 173 (Friday, September 5, 2008)]
[Notices]
[Page 51820]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-20571]


=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION


SES Performance Review Board

AGENCY: Federal Trade Commission

ACTION: Notice

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given of the appointment of members to the 
Federal Trade Commission's Performance Review Board.

FOR FURTHER INFORMATION CONTACT: Karen Leydon, Director of Human 
Resources, 600 Pennsylvania Avenue NW, Washington, DC 20580, (202) 326- 
2633.

SUPPLEMENTARY INFORMATION: Publication of the Performance Review Board 
(PRB) membership is required by 5 U.S.C. 4314 (c)(4). The PRB reviews 
and evaluates the initial appraisal of a senior executive's performance 
by the supervisor, and makes recommendations regarding performance 
ratings, performance awards, and pay-for-performance pay adjustments to 
the FTC Chairman.
    The following individuals have been designated to serve on the 
FTC's Performance Review Board:
    Charles H. Schneider, Chairman
    William Blumenthal
    Pauline M. Ippolito
    Lydia B. Parnes
    David P. Wales
    By direction of the Commission.

Donald S. Clark
Secretary
[FR Doc. E8-20571 Filed 9-4-08: 8:45 am]
BILLING CODE 6750-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.